Cart
sales@molnova.com
P505-15 Acetate
CAS No. 1370261-98-5
P505-15 Acetate( —— )
Catalog No. M34011 CAS No. 1370261-98-5
P505-15 Acetate is a selective inhibitor of spleen tyrosine kinase that acts by suppressing leukocyte immune function and inflammation and leading to a reduction in arthritis score and attenuated histological damage.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 82 | Get Quote |
|
| 5MG | 121 | Get Quote |
|
| 10MG | 186 | Get Quote |
|
| 25MG | 319 | Get Quote |
|
| 50MG | 481 | Get Quote |
|
| 100MG | 714 | Get Quote |
|
| 500MG | 1467 | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameP505-15 Acetate
-
NoteResearch use only, not for human use.
-
Brief DescriptionP505-15 Acetate is a selective inhibitor of spleen tyrosine kinase that acts by suppressing leukocyte immune function and inflammation and leading to a reduction in arthritis score and attenuated histological damage.
-
DescriptionP505-15 Acetate is a selective inhibitor of spleen tyrosine kinase that acts by suppressing leukocyte immune function and inflammation and leading to a reduction in arthritis score and attenuated histological damage.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayProteasome/Ubiquitin
-
TargetTyrosinase
-
RecptorTyrosinase
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1370261-98-5
-
Formula Weight453.5
-
Molecular FormulaC21H27N9O3
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESCC(O)=O.N[C@H]1CCCC[C@H]1Nc1ncc(C(N)=O)c(Nc2cccc(c2)-n2nccn2)n1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
Etarotene
Etarotene (Arotinoid ethyl sulphone) is an ethylsulfonyl derivative of aloe acid with differentiation-inducing and potentially antitumor activity.Etarotene is a collagenase inhibitor and can be used to study psoriasis.
-
Tyrosinase-IN-12
Tyrosinase-IN-12(Non-competitive tyrosinase inhibitor) is a potent non-competitive tyrosinase inhibitor with an IC50 of 49.33 ± 2.64 μM and a Ki of 31.25 ± 0.25 μM.
-
Paltimatrectinib
Paltimatrectinib (PBI-200) is a potent tyrosine kinase inhibitor with anticancer activity that inhibits myosin-related kinase A (TrkA).
